Infographic: Researchers Take Aim at Cancer Evolution
Infographic: Researchers Take Aim at Cancer Evolution
Strategies to trick, manipulate, and direct the evolution of tumors
Infographic: Researchers Take Aim at Cancer Evolution
Infographic: Researchers Take Aim at Cancer Evolution

Strategies to trick, manipulate, and direct the evolution of tumors

Strategies to trick, manipulate, and direct the evolution of tumors

drug resistance
Performing Metabolomic and Functional Proteomic Analyses on a Heterogenous Cancer Cell Population
Performing Metabolomic and Functional Proteomic Analyses on a Heterogenous Cancer Cell Population
The Scientist Creative Services Team in Collaboration with IsoPlexis | Mar 1, 2021
A tumor metabolome panel identifies altered cell states that lead to drug tolerance.
Harnessing Single-Cell Multi-Omic Energy States for Integrated Cancer Biology
Harnessing Single-Cell Multi-Omic Energy States for Integrated Cancer Biology
The Scientist Creative Services Team | Jan 20, 2021
Discover how scientists use multi-omic approaches to identify functional changes that lead to cancer cell drug resistance and devise new treatment strategies.
The Scientist's LabTalk - Episode 3
The Scientist's LabTalk - Episode 3
The Scientist Creative Services Team | Nov 13, 2020
Halting the Tuberculosis Epidemic with Research and Diagnostics: A Conversation with David Alland
Virus Hunters: Searching for Therapeutic Phages in a Drug Resistant World
Virus Hunters: Searching for Therapeutic Phages in a Drug Resistant World
The Scientist Creative Services Team | Sep 21, 2020
Researchers Jason Gill and Paul Turner will discuss their work on bacteriophage therapy to treat drug resistant bacterial infections.
A Multi-omics Approach to Overcome Solid Tumor Drug Resistance
A Multi-omics Approach to Overcome Solid Tumor Drug Resistance
The Scientist Creative Services Team | Aug 4, 2020
Download this research summary to learn about how single-cell proteomics and metabolomics methods unlock drug resistance mechanisms!
Cancer Researchers Use Evolution to Target Drug Resistance
Cancer Researchers Use Evolution to Target Drug Resistance
Catherine Offord | Apr 1, 2020
New therapeutic approaches in oncology aim to manipulate or block cancer’s adaptation to treatment.
Cancer Cells Increase DNA Mutations to Evade Treatment
Cancer Cells Increase DNA Mutations to Evade Treatment
Abby Olena | Nov 7, 2019
Colorectal tumor cells limit their DNA repair in response to a targeted therapy, giving them a greater chance to develop resistance to the drug.
First New Tuberculosis Drug Approved in 50 Years
First New Tuberculosis Drug Approved in 50 Years
Jef Akst | Aug 15, 2019
The US Food and Drug Administration green lights a therapy for an extreme form of multidrug resistant TB.
FDA Suspends Clinical Trials Involving Fecal Transplants
FDA Suspends Clinical Trials Involving Fecal Transplants
Chia-Yi Hou | Jun 14, 2019
The agency issued a safety warning after two patients contracted antibiotic-resistant infections and one of the patients died.